<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20892" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Eczema Herpeticum</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Xiao </surname>
            <given-names>Anny</given-names>
          </name>
          <aff>Western University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Syed</surname>
            <given-names>Hasnain A.</given-names>
          </name>
          <aff>Sheikh Zayed Hospital, Lahore</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tsuchiya</surname>
            <given-names>Arline</given-names>
          </name>
          <aff>University of California, Irvine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anny Xiao declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hasnain Syed declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Arline Tsuchiya declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>8</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20892.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Eczema herpeticum is a severe cutaneous infection caused by herpes simplex virus (HSV), primarily affecting individuals with atopic dermatitis. Characterized by the sudden appearance of monomorphic vesicles and erosions with hemorrhagic crusts over eczematous areas, this condition often manifests alongside systemic symptoms such as fever, lymphadenopathy, and malaise. It predominantly results from HSV-1 superinfection in the setting of compromised skin barriers seen in atopic dermatitis, though reactivation of HSV can also contribute. Other dermatological conditions impairing skin integrity, including Darier disease, immunobullous diseases, and burns, can similarly predispose individuals to this disseminated HSV infection, termed Kaposi varicelliform eruption (KVE).</p>
        <p>Participation in educational courses on eczema herpeticum equips healthcare professionals with a comprehensive understanding of its epidemiology, genetic underpinnings, clinical manifestations, and optimal management strategies. By acquiring knowledge through such training, participants enhance their ability to deliver timely and effective care to patients suffering from this complex and prevalent condition. Moreover, the course underscores the critical role of interprofessional collaboration in optimizing patient outcomes. Collaborative efforts involving dermatologists, infectious disease specialists, pediatricians, and nurses facilitate holistic management approaches that integrate dermatologic expertise with infectious disease management, immunological support, and psychological care. This teamwork ensures that patients receive multidisciplinary care tailored to their specific needs, ultimately improving treatment outcomes and minimizing complications associated with eczema herpeticum.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Screen patients with atopic dermatitis and other skin integrity impairments, such as Darier disease and immunobullous diseases, for early signs of eczema herpeticum.</p></list-item><list-item><p>Implement appropriate antiviral therapy and supportive care measures for patients diagnosed with eczema herpeticum to mitigate the infection and prevent complications.</p></list-item><list-item><p>Select&#x000a0;appropriate diagnostic tests, such as viral cultures or polymerase chain reaction, to confirm the presence of herpes simplex virus in suspected cases of eczema herpeticum.</p></list-item><list-item><p>Apply effective strategies to improve care coordination among interprofessional team members to facilitate positive outcomes for patients&#x000a0;with eczema herpeticum.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20892&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20892">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20892.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Eczema herpeticum is a disseminated cutaneous infection with herpes simplex virus (HSV) that develops in a patient with atopic dermatitis.<xref ref-type="bibr" rid="article-20892.r1">[1]</xref>&#x000a0;This condition&#x000a0;typically presents as a sudden onset&#x000a0;eruption of monomorphic vesicles and "punched-out" erosions with hemorrhagic crusts over eczematous areas. Patients may have systemic symptoms like fever, lymphadenopathy, or malaise.<xref ref-type="bibr" rid="article-20892.r2">[2]</xref>&#x000a0;Presentation ranges from mild and self-limiting in healthy adults to life-threatening in children, infants, and immunocompromised patients. Early treatment with antiviral therapy can&#x000a0;shorten the duration of mild disease and prevent morbidity and mortality in severe cases.<xref ref-type="bibr" rid="article-20892.r3">[3]</xref></p>
      </sec>
      <sec id="article-20892.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Eczema herpeticum is due to cutaneous superinfection with herpes simplex virus (HSV), usually HSV-1, in patients with atopic dermatitis. Cases due to&#x000a0;reactivation of HSV are more common than primary infection.<xref ref-type="bibr" rid="article-20892.r4">[4]</xref>&#x000a0;Individuals with this condition are prone to&#x000a0;recurrent bacterial and viral skin infections due to impaired epidermal barrier function and immune dysregulation.<xref ref-type="bibr" rid="article-20892.r5">[5]</xref>&#x000a0;Disseminated cutaneous HSV infection can also occur in patients with other&#x000a0;forms of dermatitis that impair the skin barrier, which is known as Kaposi varicelliform eruption (KVE).&#x000a0;KVE has been reported in patients with Darier disease, Hailey&#x02013;Hailey disease, immunobullous diseases, burns, irritant contact dermatitis, mycosis fungoides, S&#x000e9;zary syndrome, ichthyoses, and pityriasis rubra pilaris.<xref ref-type="bibr" rid="article-20892.r6">[6]</xref><xref ref-type="bibr" rid="article-20892.r7">[7]</xref>&#x000a0;</p>
        <p>Risk factors associated with developing eczema herpeticum are more severe atopic skin disease, decreased epidermal expression of filaggrin, and decreased production of cathelicidin and other antimicrobial peptides.<xref ref-type="bibr" rid="article-20892.r8">[8]</xref>&#x000a0;Affected patients exhibit biomarkers associated with T-helper type 2 (Th2) cell responses, such as reduced&#x000a0;interferon levels, elevated eosinophil count, and increased serum immunoglobulin E levels.<xref ref-type="bibr" rid="article-20892.r5">[5]</xref>&#x000a0;The Th2 shift of the immune system in patients with eczema herpeticum is associated with decreased antimicrobial peptides in the epidermis and reduced defense against cutaneous HSV infection.</p>
        <p>Eczema herpeticum patients are more likely to have food and environmental allergies, asthma, early onset of atopic dermatitis before age 5, and a history of <italic toggle="yes">Staphylococcus aureus</italic> and molluscum contagiosum infections.<xref ref-type="bibr" rid="article-20892.r5">[5]</xref>&#x000a0;The HLA-B7 allele is associated with an increased risk of eczema herpeticum.<xref ref-type="bibr" rid="article-20892.r9">[9]</xref>&#x000a0;Increased interleukin (IL)-10 and local IL-25 expression are found in&#x000a0;eczema herpeticum patients and may play a role in developing eczema herpeticum.<xref ref-type="bibr" rid="article-20892.r10">[10]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-20892.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Eczema herpeticum occurs in &#x0003c;3% of patients with atopic dermatitis, affecting infants and children more than adults.<xref ref-type="bibr" rid="article-20892.r5">[5]</xref>&#x000a0;Atopic dermatitis is the most common chronic inflammatory skin disease in the world, affecting 10% to 20% of children in developed countries and 7% to 10% of adults in the United States (US).<xref ref-type="bibr" rid="article-20892.r11">[11]</xref><xref ref-type="bibr" rid="article-20892.r12">[12]</xref>&#x000a0;Given the prevalence of HSV exposure, the comparative&#x000a0;rarity of&#x000a0;eczema herpeticum in those with atopic dermatitis suggests many host factors play an important role in the development of eczema herpeticum.</p>
        <p>Results from a study of pediatric patients with eczema herpeticum in Canada found that predictors of hospitalization included&#x000a0;male sex, age younger than 1 year, fever, and systemic symptoms at presentation.<xref ref-type="bibr" rid="article-20892.r13">[13]</xref>&#x000a0;Results from a study conducted in the US found that the average age of hospitalized pediatric patients with&#x000a0;eczema herpeticum was 3.26&#x000a0;+/- 0.1 years, and 41.8% of patients were girls. Results from this study also reported higher prevalence, length of hospital stay, and cost of care in Asian pediatric patients.<xref ref-type="bibr" rid="article-20892.r13">[13]</xref>&#x000a0;The epidemiology of&#x000a0;eczema herpeticum in nonhospitalized and adult patients is not well-defined.</p>
      </sec>
      <sec id="article-20892.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of eczema herpeticum involves a compromised epidermal barrier and dysfunctional immune responses inherent to atopic dermatitis, which predispose the skin to HSV entry and proliferation.<xref ref-type="bibr" rid="article-20892.r14">[14]</xref> In atopic dermatitis, filaggrin deficiency and cytokine-mediated inflammation weaken the skin's structural integrity, allowing HSV to penetrate more easily. The impaired skin barrier, coupled with dysregulated T-cell responses and decreased production of antimicrobial peptides, diminishes the host's ability to control viral replication. This results in widespread vesiculopustular eruptions, often accompanied by systemic symptoms such as fever and malaise.<xref ref-type="bibr" rid="article-20892.r15">[15]</xref></p>
      </sec>
      <sec id="article-20892.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histological examination of&#x000a0;eczema herpeticum reveals multinucleated giant cells with intranuclear inclusion bodies, known as Cowdry type A inclusions, within the epidermis. These inclusions are indicative of an HSV cytopathic effect. The epidermis shows extensive ballooning degeneration of keratinocytes and intraepidermal vesicle formation. There is often spongiosis and acantholysis, leading to the formation of intraepidermal and subepidermal blisters. The dermis typically exhibits a perivascular lymphocytic infiltrate, sometimes with the presence of eosinophils due to the underlying atopic dermatitis. Additionally, there may be necrosis of keratinocytes and evidence of viral replication within the lesions. These histopathological features are crucial for diagnosing and differentiating eczema herpeticum from other similar vesiculobullous disorders.<xref ref-type="bibr" rid="article-20892.r10">[10]</xref><xref ref-type="bibr" rid="article-20892.r16">[16]</xref></p>
      </sec>
      <sec id="article-20892.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Eczema herpeticum presents as a sudden onset eruption of monomorphic, dome-shaped, grouped, 2 mm to 3 mm vesicles on an erythematous base. Lesions are superimposed on areas of preexisting atopic dermatitis, most commonly on the face, neck, and upper trunk (see <bold>Image.</bold> Eczema Herpeticum). The lesions are pruritic and painful and may spread to involve normal skin over&#x000a0;7 to 10 days.<xref ref-type="bibr" rid="article-20892.r17">[17]</xref>&#x000a0;</p>
        <p>Within&#x000a0;2 weeks, the vesicles rupture&#x000a0;and form characteristic "punched-out" erosions with the hemorrhagic crust. Small erosions may coalesce to form a larger erosion or ulceration with a scalloped border. Numerous vesicles may appear in successive crops, and multiple morphologies may be present simultaneously. Lesions that are secondarily impetiginized&#x000a0;may have an overlying honey-colored crust.</p>
        <p>In patients with severe or poorly controlled atopic dermatitis, the characteristic morphology may be difficult to recognize and can be misdiagnosed as an exacerbation of eczematous dermatitis.<xref ref-type="bibr" rid="article-20892.r18">[18]</xref> Patients&#x000a0;may&#x000a0;have systemic symptoms like fever, malaise, and lymphadenopathy.<xref ref-type="bibr" rid="article-20892.r3">[3]</xref>&#x000a0;Eczema herpeticum lesions generally heal without scarring within&#x000a0;6 weeks.<xref ref-type="bibr" rid="article-20892.r19">[19]</xref></p>
      </sec>
      <sec id="article-20892.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of&#x000a0;eczema herpeticum can be made clinically if characteristic morphology is present. Viral polymerase chain reaction (PCR) can&#x000a0;be performed on vesicle fluid to confirm the diagnosis and determine the type of herpesvirus with high sensitivity and specificity. If PCR is not available, a Tzank smear, direct fluorescent antibody (DFA) testing, and viral cultures can confirm HSV infection.&#x000a0;Bacterial culture should be done if there is a concern for impetiginization. If the clinical presentation is atypical, a skin biopsy may be indicated. Laboratory tests may reveal lymphopenia and an increased erythrocyte sedimentation rate.<xref ref-type="bibr" rid="article-20892.r17">[17]</xref></p>
      </sec>
      <sec id="article-20892.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Patients with eczema herpeticum should be&#x000a0;treated promptly with systemic acyclovir or valacyclovir to&#x000a0;minimize the risk of complications and prevent progression to severe disease.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Mild cases</bold> can be treated with oral acyclovir or valacyclovir for 7 to 21 days or until all lesions are crusted over.<xref ref-type="bibr" rid="article-20892.r20">[20]</xref>&#x000a0;The recommended dosage for oral acyclovir is 30&#x000a0;mg/kg/d to 60 mg/kg/d, divided into&#x000a0;3 doses per day in children&#x000a0;and 400 mg&#x000a0;3 times per day in adults.<xref ref-type="bibr" rid="article-20892.r19">[19]</xref><xref ref-type="bibr" rid="article-20892.r21">[21]</xref>&#x000a0;The dosage for oral valacyclovir is 20 mg/kg/d in children and 500&#x000a0;mg 3 times per day in adults.<xref ref-type="bibr" rid="article-20892.r4">[4]</xref>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Severe cases</bold> or those who are&#x000a0;<bold>immunocompromised</bold>&#x000a0;should be hospitalized for intravenous acyclovir (5 mg/kg to 10 mg/kg every 8 hours). Once clinical improvement occurs and the lesions start to crust over, patients can be transitioned to oral acyclovir.<xref ref-type="bibr" rid="article-20892.r18">[18]</xref>&#x000a0;Supportive care with gentle emollients and cool compresses can provide symptomatic relief.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Those who are<bold> critically ill</bold>&#x000a0;may need&#x000a0;intravenous fluids, electrolyte repletion, wound care, pain control, and nutritional support. Patients should be counseled about the risk of autoinoculation, and frequent handwashing should be encouraged. Eczema herpeticum lesions are considered infectious until&#x000a0;crusted over.</p>
          </list-item>
          <list-item>
            <p><bold>Contact precautions</bold> should be initiated for those who are hospitalized, including patient isolation and the use of face masks and gowns for healthcare professionals.<xref ref-type="bibr" rid="article-20892.r21">[21]</xref>&#x000a0;Patients should be monitored for the development of secondary bacterial infections and treated with systemic antibiotics according to&#x000a0;culture and susceptibility results.<xref ref-type="bibr" rid="article-20892.r21">[21]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20892.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for&#x000a0;eczema herpeticum includes the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Impetigo</p>
          </list-item>
          <list-item>
            <p>Hand-foot-and-mouth disease</p>
          </list-item>
          <list-item>
            <p>Eczema coxsackium</p>
          </list-item>
          <list-item>
            <p>Primary varicella infection</p>
          </list-item>
          <list-item>
            <p>Disseminated herpes zoster</p>
          </list-item>
          <list-item>
            <p>Disseminated molluscum contagiosum</p>
          </list-item>
          <list-item>
            <p>Acute generalized exanthematous pustulosis</p>
          </list-item>
          <list-item>
            <p>Dermatitis herpetiformis</p>
          </list-item>
          <list-item>
            <p>Cellulitis</p>
          </list-item>
          <list-item>
            <p>Erysipelas</p>
          </list-item>
        </list>
        <p>Misdiagnosis of&#x000a0;eczema herpeticum can lead to delayed initiation of antiviral treatment and subsequent complications. Diagnostic clues that favor&#x000a0;eczema herpeticum are&#x000a0;painful lesions, monomorphic size of the lesions, and characteristic "punched-out" erosions in areas of preexisting atopic dermatitis. Unlike herpes zoster,&#x000a0;eczema herpeticum does not respect dermatomal boundaries.</p>
      </sec>
      <sec id="article-20892.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Eczema herpeticum is a potentially life-threatening disease with mortality risk due to complications of systemic viremia, bacteremia, and fungal infection leading to multiorgan failure.<xref ref-type="bibr" rid="article-20892.r22">[22]</xref> Before using acyclovir, mortality rates in patients with eczema herpeticum were reportedly 10% to 50%.<xref ref-type="bibr" rid="article-20892.r23">[23]</xref>&#x000a0;Since the widespread implementation of systemic antiviral treatment, mortality rates have decreased significantly.</p>
        <p>Results from a 2011 study of 1331 pediatric&#x000a0;eczema herpeticum patients hospitalized in the US found no deaths and concluded that the mortality rate of hospitalized patients is low.&#x000a0;The median length of hospital stay was&#x000a0;3 days, with 9.2% of patients requiring hospitalization longer than&#x000a0;1 week and 3.8% requiring intensive care unit admission.<xref ref-type="bibr" rid="article-20892.r24">[24]</xref>&#x000a0;</p>
        <p>Results from a study conducted in 2018 showed that 4655 hospitalized children with&#x000a0;eczema herpeticum had a mortality rate of 0.1%, and 98.1% of patients were classified as having a minor mortality risk. Only 4.5% of patients were classified as having a major loss of function, while 33.1% had moderate, and the majority had a minor loss of function.<xref ref-type="bibr" rid="article-20892.r13">[13]</xref></p>
      </sec>
      <sec id="article-20892.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Potential complications of&#x000a0;eczema herpeticum include cutaneous superinfection with <italic toggle="yes">Staphylococcus aureus</italic>, <italic toggle="yes">Streptococcus pyogenes</italic>, and molluscum contagiosum virus.<xref ref-type="bibr" rid="article-20892.r25">[25]</xref><xref ref-type="bibr" rid="article-20892.r26">[26]</xref>&#x000a0;Results from a study by Aronson et al found&#x000a0;<italic toggle="yes">S aureus</italic>&#x000a0;infection in 30.3% of patients who were pediatric and hospitalized with pediatric&#x000a0;eczema, with&#x000a0;9.2% due to methicillin-resistant&#x000a0;<italic toggle="yes">S aureus and&#x000a0;</italic>3.9% with bacteremia.&#x000a0;Eighty-six percent of patients were treated with oral or intravenous antibiotics.<xref ref-type="bibr" rid="article-20892.r24">[24]</xref>&#x000a0;Additional complications include meningoencephalitis and herpetic keratoconjunctivitis, which can result in scarring and blindness.<xref ref-type="bibr" rid="article-20892.r4">[4]</xref>&#x000a0;Disseminated systemic infections of HSV leading to bone marrow suppression, disseminated intravascular coagulation, and death have been reported.<xref ref-type="bibr" rid="article-20892.r18">[18]</xref></p>
      </sec>
      <sec id="article-20892.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>A dermatology consult may be beneficial to confirm the diagnosis of eczema herpeticum. An ophthalmologic evaluation is warranted in cases involving the face and eyelids.</p>
      </sec>
      <sec id="article-20892.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Effective deterrence and patient education are crucial in managing eczema herpeticum. Preventing outbreaks involves educating patients and caregivers about proper skin care routines, recognizing early signs of infection, and understanding the importance of prompt medical attention. Patients with atopic dermatitis should be informed about the risk factors for eczema herpeticum, such as severe or poorly controlled dermatitis, and the need to avoid potential triggers, including certain allergens and skin irritants. Healthcare professionals should emphasize the significance of maintaining a robust skincare regimen, using prescribed medications, and attending regular follow-up appointments.</p>
        <p>Patients with eczema herpeticum should be counseled that they are infectious until all lesions have crusted over and thus should avoid close contact with others until then.&#x000a0;Affected individuals must be encouraged to avoid scratching and should wash their hands frequently due to the risk of autoinoculation.&#x000a0;Patients diagnosed with mild&#x000a0;eczema herpeticum and treated as outpatients should be cautioned to seek emergency care if they develop systemic symptoms or worsening rash, as they may require hospitalization, intravenous acyclovir treatment, or antibiotic coverage.&#x000a0;Immediate treatment can significantly reduce the incidence and severity of eczema herpeticum, ultimately improving patient outcomes and quality of life.</p>
      </sec>
      <sec id="article-20892.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Understanding key clinical insights is essential for effectively managing eczema herpeticum. Some clinical pearls&#x000a0;that help guide diagnosis, treatment, and patient education include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Early recognition:</bold> Identify eczema herpeticum by its characteristic sudden-onset vesicular rash and "punched-out" erosions, often overlying areas of atopic dermatitis.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Prompt treatment:</bold> Initiate systemic antiviral therapy immediately upon suspicion to reduce morbidity and prevent complications.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Risk factors:</bold> Patients with severe atopic dermatitis, frequent allergies, asthma, early-onset dermatitis, and a history of skin infections are at higher risk.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Differential diagnosis:</bold> Differentiate eczema herpeticum from bacterial infections, impetigo, and other viral exanthems.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Systemic symptoms:</bold> Look for systemic signs such as fever, lymphadenopathy, and malaise, which may accompany the skin findings.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Secondary infections:</bold> Monitor for and treat any secondary bacterial infections promptly.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Patient education:</bold> Educate patients and caregivers on the importance of early symptom recognition and seeking immediate medical care.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Preventive measures:</bold> Encourage strict adherence to prescribed skincare regimens to maintain the skin barrier function and reduce the risk of HSV infection.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Care coordination:</bold> Ensure seamless communication and coordination among interprofessional healthcare&#x000a0;team members to effectively manage and follow up on&#x000a0;affected patients.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Follow-up care:</bold> Schedule regular follow-up appointments to monitor patient progress and adjust treatment plans as necessary.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20892.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Managing eczema herpeticum requires an interprofessional team of physicians, advanced care practitioners, nurses, pharmacists, and other healthcare professionals. Each team member is responsible for specific clinical roles. Physicians and advanced care practitioners must develop skills to promptly recognize the clinical signs of eczema herpeticum, such as uniform vesicles and "punched-out" erosions. Advanced knowledge in prescribing and managing systemic antiviral therapies is crucial for physicians, nurse practitioners, and pharmacists. Nurses should be adept in wound care management, patient monitoring, and educating patients on symptom recognition and care strategies.</p>
        <p>The interprofessional team is critical in&#x000a0;implementing protocols for the early detection and treatment of eczema herpeticum to prevent adverse effects and complications. Developing and executing integrated care plans that involve multiple healthcare professionals&#x000a0;will address all aspects of the patient's condition. Collaborating and establishing effective communication channels&#x000a0;is important to ensure comprehensive care while reducing morbidity and mortality associated with eczema herpeticum.</p>
        <p>Affected patients and their families should be educated about their condition, treatment options, and prevention strategies. Coordinating follow-up care to monitor the patient's progress and address any emerging issues is essential. By fostering a collaborative, patient-centered approach, interprofessional healthcare teams can improve the quality of care for patients with eczema herpeticum, ultimately leading to better health outcomes and enhanced team performance.</p>
      </sec>
      <sec id="article-20892.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20892&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20892">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/eczema-herpeticum/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20892">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20892/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20892">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-20892.s18">
        <fig id="article-20892.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Eczema Herpeticum <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="eczema__herpeticum" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-20892.s19">
        <title>References</title>
        <ref id="article-20892.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Micali</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lacarrubba</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Eczema Herpeticum.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Aug</month>
            <day>17</day>
            <volume>377</volume>
            <issue>7</issue>
            <fpage>e9</fpage>
            <pub-id pub-id-type="pmid">28813215</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seegr&#x000e4;ber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Worm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Werfel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Svensson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Novak</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Darsow</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Augustin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wollenberg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Recurrent eczema herpeticum - a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2020</year>
            <month>May</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>1074</fpage>
            <page-range>1074-1079</page-range>
            <pub-id pub-id-type="pmid">31733162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vera-Kellet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hasb&#x000fa;n</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Eczema herpeticum: A medical emergency in patients with atopic dermatitis.</article-title>
            <source>IDCases</source>
            <year>2020</year>
            <volume>19</volume>
            <fpage>e00663</fpage>
            <pub-id pub-id-type="pmid">32226756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wollenberg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wetzel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Burgdorf</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Haas</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Viral infections in atopic dermatitis: pathogenic aspects and clinical management.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>112</volume>
            <issue>4</issue>
            <fpage>667</fpage>
            <page-range>667-74</page-range>
            <pub-id pub-id-type="pmid">14564342</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leung</surname>
                <given-names>DY</given-names>
              </name>
            </person-group>
            <article-title>Why is eczema herpeticum unexpectedly rare?</article-title>
            <source>Antiviral Res</source>
            <year>2013</year>
            <month>May</month>
            <volume>98</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <page-range>153-7</page-range>
            <pub-id pub-id-type="pmid">23439082</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lehman</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>el-Azhary</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Kaposi varicelliform eruption in patients with autoimmune bullous dermatoses.</article-title>
            <source>Int J Dermatol</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>55</volume>
            <issue>3</issue>
            <fpage>e136</fpage>
            <page-range>e136-40</page-range>
            <pub-id pub-id-type="pmid">26500144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Martini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Philips</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sharp</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tarbox</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Darier disease with disseminated herpes simplex virus type 2 infection.</article-title>
            <source>Dermatol Online J</source>
            <year>2019</year>
            <month>Apr</month>
            <day>15</day>
            <volume>25</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">31046908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hata</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Kotol</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Boguniewicz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Paik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kabigting</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gerber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zaccaro</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dorschner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Gallo</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>History of eczema herpeticum is associated with the inability to induce human &#x003b2;-defensin (HBD)-2, HBD-3 and cathelicidin in the skin of patients with atopic dermatitis.</article-title>
            <source>Br J Dermatol</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>163</volume>
            <issue>3</issue>
            <fpage>659</fpage>
            <page-range>659-61</page-range>
            <pub-id pub-id-type="pmid">20545685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mathias</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Weinberg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boguniewicz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zaccaro</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Hata</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Hanifin</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Beck</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>DY</given-names>
              </name>
            </person-group>
            <article-title>Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferon-&#x003b3;-producing CD8+ T cells.</article-title>
            <source>Br J Dermatol</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>169</volume>
            <issue>3</issue>
            <fpage>700</fpage>
            <page-range>700-3</page-range>
            <pub-id pub-id-type="pmid">23600999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Damour</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seneschal</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>L&#x000e9;v&#x000ea;que</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bodet</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Eczema Herpeticum: Clinical and Pathophysiological Aspects.</article-title>
            <source>Clin Rev Allergy Immunol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-18</page-range>
            <pub-id pub-id-type="pmid">31836943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lyons</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Milner</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Atopic dermatitis in children: clinical features, pathophysiology, and treatment.</article-title>
            <source>Immunol Allergy Clin North Am</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>161</fpage>
            <page-range>161-83</page-range>
            <pub-id pub-id-type="pmid">25459583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silverberg</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Hanifin</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>132</volume>
            <issue>5</issue>
            <fpage>1132</fpage>
            <page-range>1132-8</page-range>
            <pub-id pub-id-type="pmid">24094544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hsu</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Shinkai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Silverberg</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Eczema Herpeticum in&#x000a0;Hospitalized U.S. Children: Analysis of&#x000a0;a&#x000a0;Nationwide Cohort.</article-title>
            <source>J Invest Dermatol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>138</volume>
            <issue>2</issue>
            <fpage>265</fpage>
            <page-range>265-272</page-range>
            <pub-id pub-id-type="pmid">28927889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Traidl</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roesner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zeitvogel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Werfel</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Eczema herpeticum in atopic dermatitis.</article-title>
            <source>Allergy</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>76</volume>
            <issue>10</issue>
            <fpage>3017</fpage>
            <page-range>3017-3027</page-range>
            <pub-id pub-id-type="pmid">33844308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Branco</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Ribeiro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ribeiro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Policarpo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Enes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>JML</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sarmento</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ceia</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Eczema herpeticum.</article-title>
            <source>IDCases</source>
            <year>2021</year>
            <volume>26</volume>
            <fpage>e01299</fpage>
            <pub-id pub-id-type="pmid">34660201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>VV</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Squires</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tonkovic-Capin</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Eczema herpeticum in a patient With Hailey-Hailey disease confounded by coexistent psoriasis.</article-title>
            <source>Cutis</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>105</volume>
            <issue>6</issue>
            <fpage>E38</fpage>
            <page-range>E38-E41</page-range>
            <pub-id pub-id-type="pmid">32717004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wollenberg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zoch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wetzel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Plewig</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Przybilla</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>49</volume>
            <issue>2</issue>
            <fpage>198</fpage>
            <page-range>198-205</page-range>
            <pub-id pub-id-type="pmid">12894065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhuang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Ran</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ran</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Lei</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lama</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Oral treatment with valacyclovir for HSV-2-associated eczema herpeticum in a 9-month-old infant: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>95</volume>
            <issue>29</issue>
            <fpage>e4284</fpage>
            <pub-id pub-id-type="pmid">27442669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luca</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Lara-Corrales</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pope</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Eczema herpeticum in children: clinical features and factors predictive of hospitalization.</article-title>
            <source>J Pediatr</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>161</volume>
            <issue>4</issue>
            <fpage>671</fpage>
            <page-range>671-5</page-range>
            <pub-id pub-id-type="pmid">22575249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atherton</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>Management of eczema herpeticum.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1988</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>4 Pt 1</issue>
            <fpage>757</fpage>
            <page-range>757-8</page-range>
            <pub-id pub-id-type="pmid">3372774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sohail</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Shami</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Bashir</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Management of eczema herpeticum in a Burn Unit.</article-title>
            <source>J Pak Med Assoc</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>66</volume>
            <issue>11</issue>
            <fpage>1357</fpage>
            <page-range>1357-1361</page-range>
            <pub-id pub-id-type="pmid">27812048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wollenberg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Eczema herpeticum.</article-title>
            <source>Chem Immunol Allergy</source>
            <year>2012</year>
            <volume>96</volume>
            <fpage>89</fpage>
            <page-range>89-95</page-range>
            <pub-id pub-id-type="pmid">22433376</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wheeler</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Abele</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Eczema herpeticum, primary and recurrent.</article-title>
            <source>Arch Dermatol</source>
            <year>1966</year>
            <month>Feb</month>
            <volume>93</volume>
            <issue>2</issue>
            <fpage>162</fpage>
            <page-range>162-73</page-range>
            <pub-id pub-id-type="pmid">4159394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aronson</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Mohamad</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Delayed acyclovir and outcomes of children hospitalized with eczema herpeticum.</article-title>
            <source>Pediatrics</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>128</volume>
            <issue>6</issue>
            <fpage>1161</fpage>
            <page-range>1161-7</page-range>
            <pub-id pub-id-type="pmid">22084327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beck</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Boguniewicz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Hanifin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gallo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Paller</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Lieff</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reese</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zaccaro</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Milgrom</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>DY</given-names>
              </name>
            </person-group>
            <article-title>Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>124</volume>
            <issue>2</issue>
            <fpage>260</fpage>
            <page-range>260-9, 269.e1-7</page-range>
            <pub-id pub-id-type="pmid">19541356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20892.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Narla</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Silverberg</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>Association between atopic dermatitis and serious cutaneous, multiorgan and systemic infections in US adults.</article-title>
            <source>Ann Allergy Asthma Immunol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>120</volume>
            <issue>1</issue>
            <fpage>66</fpage>
            <page-range>66-72.e11</page-range>
            <pub-id pub-id-type="pmid">29273131</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
